Clinical Trials Directory

Trials / Sponsors / Ironshore Pharmaceuticals and Development, Inc

Ironshore Pharmaceuticals and Development, Inc

Academic / Other · 7 registered clinical trials.

StatusTrialPhaseStarted
TerminatedEfficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHD
Attention Deficit Hyperactivity Disorder
Phase 32024-09-13
CompletedA Study of Delayed and Extended Release Formulation of Dextroamphetamine Sulfate (HLD100) in Children With ADH
Attention-Deficit Hyperactivity Disorder (ADHD)
Phase 22016-08-01
CompletedA Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic Setting
Attention Deficit Hyperactivity Disorder
Phase 32015-08-01
CompletedA Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Classroom Setting
Attention Deficit Hyperactivity Disorder
Phase 32015-07-01
CompletedA Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD
Attention Deficit Hyperactivity Disorder
Phase 32014-05-01
CompletedPharmacokinetics of HLD200 in Children and Adolescents With ADHD
Attention-Deficit Hyperactivity Disorder
Phase 1 / Phase 22013-08-01
CompletedA Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Releas
Attention-Deficit Hyperactivity Disorder
Phase 1 / Phase 22013-07-01